Medical News

RSS

Malaria parasite found to evade the immune system by shutting down key genes

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body's immune system, sometimes for years.

16 May 2025

Lithuanian researchers develop breakthrough stroke monitoring system

Stroke is one of the leading causes of long-term disability worldwide. According to the World Health Organization, approximately 15 million people suffer a stroke each year.

16 May 2025

Seventy-eighth World Health Assembly set to begin in May 2025

The Seventy-eighth session of the World Health Assembly (WHA78) will convene from 19 to 27 May 2025 in Geneva, Switzerland, under the theme "One World for Health".

16 May 2025

Pharmacists stockpile most common drugs on chance of targeted Trump tariffs

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.

16 May 2025

Even where abortion is still legal, many brick-and-mortar clinics are closing

On the last day of patient care at the Planned Parenthood clinic in Marquette, Michigan, a port town on the shore of Lake Superior, dozens of people crowded into the parking lot and alley, holding pink homemade signs that read "Thank You!" and "Forever Grateful."

16 May 2025

Californians receiving in-home care fear Medicaid cuts will spell end to independent living

With a Starbucks coffee cup in her hand and a half gallon of milk under her arm, Florence Owens let herself into Carol Crooks' apartment on a Monday morning, announced herself with a cheery "hello," walked through the book-filled living room, and got to work in the kitchen.

16 May 2025

Optimer licensing agreements and repeat custom

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has announced two new development contracts for Optimer binders and the agreement of licensing heads of terms with a global provider of specialty enzymes for developed enzyme-modulating Optimers.

From Aptamer Group 16 May 2025

Aptamer announces new data at ASGCT

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).

From Aptamer Group 16 May 2025

Socioeconomic gaps persist in COVID-19 vaccination among older Swedes

The spring COVID-19 vaccination program in Sweden is in its final stages in several parts of the country. The program has encompassed free booster doses for those at increased risk of serious illness, including the very oldest members of society.

16 May 2025

Study links air pollution, urban development and lack of green spaces to asthma

The combination of air pollution, dense urban development and limited green spaces increases the risk of asthma in both children and adults.

16 May 2025

Wuxi Biologics completes first commercial PPQ campaign at 15,000L production line in Hangzhou site

WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the successful completion of the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000L single-use bioreactors (SUBs) in the second drug substance line of its MFG20 facility at the Hangzhou site.

16 May 2025

Disparities in access to novel infusion treatment for Alzheimer's disease revealed

Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have higher socioeconomic status, new research suggests.

15 May 2025

$Discovery of mutated immune cell clones could point to improved treatment for refractory celiac disease$

Discovery of mutated immune cell clones could point to improved treatment for refractory celiac disease

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

15 May 2025

Peptide nanostructures block amyloid buildup and boost neuron survival in lab tests

Researchers developed trehalose-functionalized peptide amphiphiles (TPAs) that self-assemble into supramolecular nanostructures and demonstrated these TPAs can inhibit amyloid beta aggregation. In vitro, TPAs significantly improved survival of human neurons exposed to amyloid-induced neurotoxicity, suggesting therapeutic potential for neurodegenerative diseases.

15 May 2025

Study shows how lung capacity evolves from childhood to old age

A study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by "la Caixa" Foundation, in collaboration with the Clínic-IDIBAPS, has shown for the first time, how lung capacity evolves from childhood to old age.

15 May 2025

$Testosterone gel fails to boost recovery after hip fracture in women$

Testosterone gel fails to boost recovery after hip fracture in women

Hip fractures, often a result of a fall, are the most serious type of osteoporotic fracture because they are accompanied by considerable pain, loss of muscle and bone strength, reduced mobility and independence with daily activities, and increased risk for future fractures and death.

15 May 2025

US hospitals see rising complications in patients with takotsubo cardiomyopathy

A large US study found that takotsubo cardiomyopathy is associated with high in-hospital mortality and serious cardiovascular complications, with no improvements in outcomes over five years. Mortality is more than double in men compared to women, and risk factors include age, race, and hospital characteristics.

15 May 2025